TIVDAK® (tisotumab vedotin-tftv) Patient Guide
On this page
What is TIVDAK?
- TIVDAK is a prescription medicine used to treat adult patients with recurrent or metastatic cervical cancer (cancer of the the cervix) whose disease has progressed after chemotherapy.
- It is a type of therapy called an antibody-drug conjugate (ADC), which targets cancer cells and delivers a cytotoxic (cell-killing) agent directly to them.
Important Safety Warning
- TIVDAK can cause serious eye problems, including injury to the surface of your eye, ulcers, vision changes, or even permanent vision loss.
- This is the most important risk to be aware of. You must closely follow the required eye care plan before, during, and after each infusion.
- If you develop new or worsening eye symptoms or vision changes, contact your doctor or eye-care provider immediately.
What to Tell Your Doctor Before Starting TIVDAK
Before you start TIVDAK, tell your doctor if you:
- Have any eye or vision problems
- Wear contact lenses
- Have numbness, tingling, or weakness in your hands or feet
- Have bleeding or blood clotting problems
- Have liver problems
- Are pregnant, planning to become pregnant, or breastfeeding
- Are taking other medications, especially ones that strongly affect the liver enzyme CYP3A4 (these may increase risk of side effects)
How TIVDAK Is Given / What to Expect
- You will get TIVDAK by intravenous (IV) infusion over 30 minutes every 3 weeks, until your disease worsens or you develop unacceptable side effects.
- The full infusion appointment may take about 60 minutes, including applying eye drops, cold packs, etc.
- Your dose is usually 2.0 mg per kg of body weight, up to a maximum of 200 mg (for patients weighing ≥ 100 kg)
- If side effects occur, your doctor may delay, reduce, or stop TIVDAK treatment.

Eye Care Plan / What You Must Do
Your eye health is critical while on TIVDAK. The following steps help reduce the risk of eye damage:
- Eye Exams
- Before you start TIVDAK
- Before every dose (for the first 9 cycles)
- As your eye doctor recommends after that
- Eye Drops & Eye Protection
- Use corticosteroid eye drops before, during, and after each infusion (as instructed)
- Use lubricating (artificial tear) eye drops regularly during treatment and continue for 30 days after stopping TIVDAK
- Use cold eye pads during infusion to protect the eyes
- Use vasoconstrictor eye drops prior to infusion (as directed)
- Do not use contact lenses during treatment unless your eye doctor says it’s okay
- Report Eye Symptoms Promptly
Tell your doctor or eye-care provider right away if you have new or worsening:- Blurred vision
- Eye pain, redness, irritation
- Sensation of something in your eye
- Changes in tear production or dryness
Possible Side Effects / What to Watch For
Some side effects are common; some can be serious:
Common Side Effects (seen in ≥25% of patients)
- Decreased red blood cell counts (anemia)
- Numbness or tingling (peripheral neuropathy)
- Eye problems (conjunctivitis, dry eye)
- Nausea
- Feeling tired (fatigue)
- Elevated liver enzymes (AST, ALT)
- Nosebleed (epistaxis)
- Hair loss (alopecia)
- Bleeding (hemorrhage)
Serious Side Effects You Should Know About
- Severe eye toxicity, including ulcers, vision changes, corneal damage, and possibly permanent vision loss
- Peripheral neuropathy (nerve damage) — numbness, tingling, weakness in arms or legs; may require dose changes or stopping treatment
- Bleeding / Hemorrhage — nosebleeds are common; more serious bleeding (e.g. GI bleeding) is possible
- Pneumonitis (lung inflammation) — may be severe; symptoms include shortness of breath, cough, fever
- Severe skin reactions, including Stevens-Johnson syndrome (SJS) — a rare but serious rash that requires immediate medical attention
- Death — in clinical trials, some fatal side effects occurred (e.g., sepsis, pneumonitis)
What Your Doctor Will Do to Monitor You
Your medical team will order tests and check for side effects, including:
- Eye exams before and during treatment (as described above)
- Complete blood counts (CBC) to watch for anemia or low blood cells
- Liver function tests (AST, ALT, bilirubin) to detect liver injury
- Kidney function tests (creatinine, BUN)
- Neurologic assessments (checking for neuropathy)
- Pulmonary monitoring (if you develop cough, breathing changes)
- Skin checks (for rash or blistering)
If you develop side effects, your doctor might hold, reduce, or permanently stop TIVDAK depending on severity.
Pregnancy, Breastfeeding & Contraception
- TIVDAK can harm an unborn baby. Do not use it if you’re pregnant.
- Women of reproductive potential must use effective contraception during treatment and for 2 months after the last dose.
- Men with female partners of childbearing potential must use effective contraception during treatment and for 4 months after the last dose.
- It is unknown if TIVDAK is safe while breastfeeding—do not breastfeed during treatment.
Drug Interactions
- TIVDAK’s active part (MMAE) is processed by the CYP3A4 enzyme
- Using strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) at the same time may increase the risk of TIVDAK side effects.
- Always tell your doctor or pharmacist about all medicines—prescription, over-the-counter, vitamins, herbal supplements.
What You Can Do to Stay Safe / Tips for Patients
- Keep all your eye appointments and follow eye-care instructions exactly
- Use all eye drops as instructed
- Report any new symptoms right away—vision changes, eye pain, tingling or numbness in hands/feet, bleeding, cough or breathing trouble, rash, or other unexpected problems
- Avoid contact lenses during treatment (unless doctor says it’s safe)
- Use good skin care—moisturizers, gentle products
- Avoid injury and bleeding—use soft toothbrushes, avoid NSAIDs unless approved
- Keep a list of all your medications and bring them to your visits
When to Call Your Health Care Team Immediately
Call your doctor or go to the ER if you experience:
- Sudden or worsening vision changes
- Severe eye pain, redness, or discharge
- New or worsening numbness, burning, tingling, or muscle weakness in your arms or legs
- Unexpected bleeding (heavy nosebleed, blood in stool/urine, coughing up blood)
- New or worsening shortness of breath, cough, or chest pain
- Severe skin rash, blisters, peeling, mouth sores, or fever
- Signs of infection (fever, chills, sore throat)
Support & Resources
- There is a TIVDAK Patient Brochure and a Caregiver Brochure you can request through your doctor or via the official site. https://www.tivdakhcp.com/
- A support program called Seagen Secure® may help with access, insurance, and financial support.
- You may sign up for TivdakTexts, a text-messaging program to help remind you of infusion and eye care steps.
Summary / Key Points to Remember
- TIVDAK is used for certain cervical cancers when chemotherapy no longer works.
- The most serious risk is eye damage—strict eye care and monitoring are required
- Other risks include nerve damage, bleeding, lung problems, skin reactions
- Your medical team will monitor you closely, and may adjust or stop TIVDAK if side effects happen
- Always report symptoms promptly